Some Amazon villagers eschew drugs for COVID-19, take 'toothache plant' herbal tea
Some villagers in the eastern Amazon are spurning Brazilian government advice to take the malaria drug hydroxychloroquine to keep the novel coronavirus at bay and are drinking tea of jamb ú, also known as the toothache plant. (Source: Reuters: Health)
Source: Reuters: Health - June 16, 2020 Category: Consumer Health News Tags: healthNews Source Type: news
‘India not to stop hydroxychloroquine treatment in mild cases'
HCQ, currently used to treat lupus and rheumatoid arthritis, has split world opinion on its use in Covid-19 management, even as India said the decision was “taken based on risk-benefit assessment.” (Source: The Economic Times)
Source: The Economic Times - June 16, 2020 Category: Consumer Health News Source Type: news
Surgisphere Sows Confusion About Another Unproven COVID-19 Drug
The company behind a now-discredited study on hydroxychloroquine also posted a report that has been cited by Latin American governments recommending ivermectin as a possible coronavirus treatment.... (Source: The Scientist)
Source: The Scientist - June 16, 2020 Category: Science Tags: News & Opinion Source Type: news
Hydroxychloroquine-Remdesivir Combo Dangerous: FDA
The drugs, hydroxychloroquine and chloroquine, could reduce the antiviral effectiveness of remdesivir, the FDA warned Monday (Source: WebMD Health)
Source: WebMD Health - June 16, 2020 Category: Consumer Health News Source Type: news
FDA Pulls Emergency Use Authorization for Antimalarial Drugs
Hydroxychloroquine and chloroquine, once thought to be promising COVID-19 treatments, come with serious heart risks. (Source: The Scientist)
Source: The Scientist - June 16, 2020 Category: Science Tags: News & Opinion Source Type: news
Hydroxychloroquine-Remdesivir Combo Dangerous for COVID-19 Patients
TUESDAY, June 16, 2020 -- In the treatment of COVID-19 patients, chloroquine phosphate or hydroxychloroquine sulfate should not be used with the experimental drug remdesivir because of a potentially unfavorable drug interaction, the U.S. Food and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 16, 2020 Category: Pharmaceuticals Source Type: news
A Low-Cost Steroid Shows Promise for Treating COVID-19. But Take the News With a Grain of Salt
Encouraging results from researchers looking into potential COVID-19 treatments are being hailed as a “groundbreaking development”—but recent history shows it’s worth taking these promising findings with a grain of salt.
Investigators working on the U.K.-based RECOVERY trial announced today that dexamethasone, a low-cost and widely available steroid that lowers inflammation, improved patients’ chances of surviving severe COVID-19. During the study, about 2,100 COVID-19 patients were treated with dexamethasone for 10 days. Patients on mechanical ventilation who were given dexamethasone were 35%...
Source: TIME: Health - June 16, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news
FDA Warns Against Combination of Malaria Drug and Gilead's Remdesivir FDA Warns Against Combination of Malaria Drug and Gilead's Remdesivir
The US FDA on Monday issued a warning to healthcare providers against administering malaria drug hydroxychloroquine or chloroquine in combination with Gilead Sciences ' experimental COVID-19 drug, remdesivir.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 16, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news
MHRA suspends recruitment to COVID-19 hydroxychloroquine trials, MHRA
The Medicines and Healthcare products Regulatory Agency (MHRA) has instructed UK clinical trialists using hydroxychloroquine to treat or prevent coronavirus (COVID-19) to suspend recruitment of further participants. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 16, 2020 Category: Consumer Health News Source Type: news
Africa: Low-cost Dexamethasone Reduces Death in Hospitalised Patients with Severe COVID-19
[Recovery] Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on hydroxychloroquine, 16 June 2020 (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 16, 2020 Category: African Health Source Type: news
U.K. Researchers Say They Have Found First Drug that Improves COVID-19 Survival
Researchers in England say they have the first evidence that a drug can improve COVID-19 survival: A steroid called dexamethasone reduced deaths by up to one third in severely ill hospitalized patients.
Results were announced Tuesday and researchers said they would publish them soon. The study is a large, strict test that randomly assigned 2,104 patients to get the drug and compared them with 4,321 patients getting only usual care.
The drug was given either orally or through an IV. It reduced deaths by 35% in patients who needed treatment with breathing machines and by 20% in those only needing supplemental oxygen. It did ...
Source: TIME: Science - June 16, 2020 Category: Science Authors: MARILYNN MARCHIONE /AP Tags: Uncategorized Source Type: news
Hydroxychloroquine-Remdesivir Combo Dangerous for COVID-19 Patients: FDA
TUESDAY, June 16, 2020 -- The drugs promoted by President Donald Trump as treatments for COVID-19 should not be used with the experimental drug remdesivir because of a potentially unfavorable drug interaction, the U.S. Food and Drug Administration... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 16, 2020 Category: General Medicine Source Type: news
Coronavirus live news: New Zealand records first new cases for weeks as Beijing closes sports halls
China reimposes partial lockdown in capital to tackle new cluster; US authorities revoke emergency use of hydroxychloroquine; two imported cases in NZ. Follow the latest updatesNew Zealand reports two cases in returning travellersBeijing lockdown tightens as new coronavirus outbreak spreadsUS revokes emergency approval of hydroxychloroquine for Covid-19Covid-19 can damage lungs of victims beyond recognition, expert saysSee all our coronavirus coverage4.16amBSTIn a move likely to cause further tension between the US and the World Health Organization, the WHO chief, Tedros Adhanom Ghebreyesus, is scheduled to give a commence...
Source: Guardian Unlimited Science - June 16, 2020 Category: Science Authors: Alison Rourke Tags: Coronavirus outbreak China Trump administration US politics Brazil Science World news India Source Type: news
Trump DOESN'T believe FDA as it issues another hydroxy warning
President Trump said Monday that he's 'heard some great reports' about the effectiveness of hydroxychloroquine treating the coronavirus. (Source: the Mail online | Health)
Source: the Mail online | Health - June 16, 2020 Category: Consumer Health News Source Type: news
Hydroxychloroquine: US revokes emergency approval of malaria drug for Covid-19
Food and Drug Administration says drug is unlikely to work against coronavirus and notes heart risksCoronavirus – latest updatesUS regulators revoked the emergency authorization for malaria drugs championed by Donald Trump for treating Covid-19, amidgrowing evidence they don ’t work and could cause serious side effects.The Food and Drug Administration (FDA) said on Monday the drugs hydroxychloroquine and chloroquine were unlikely to be effective in treating the coronavirus. Citing reports of heart complications, the agency said the drugs ’ unproven benefits “do not outweigh the known and potential risks”.Continue...
Source: Guardian Unlimited Science - June 16, 2020 Category: Science Authors: Guardian staff and agencies Tags: Coronavirus outbreak US news Health US healthcare Society Science Infectious diseases Medical research World news Source Type: news
